Dupilumab skin barrier function study in atopic dermatitis

Trial Identifier:	LPS15991
Sponsor:	Sanofi
Collaborator:	Regeneron
Start Date:	July 2020
Primary Completion Date:	June 2021
Study Completion Date:	June 2021
Condition:	Eczema

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
CANADA	Montreal, CANADA, H2X 2V1
UNITED STATES, Colorado	Denver, Colorado, UNITED STATES, 80206

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.